March 14, 2008 – Schering-Plough this week said the FDA Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval after reviewing data on the safety and efficacy of the medication.
The FDA is not bound by the committee’s recommendations, however, its recommendations are usually considered carefully before a final decision on approval is made.